Travere Therapeutics, Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2013 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Travere Therapeutics, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2013 to Q4 2023.
  • Travere Therapeutics, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $22.9M, a 99.4% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $22.9M +$11.4M +99.4% Dec 31, 2023 10-K 2024-02-20
Q4 2022 $11.5M +$3.67M +46.8% Dec 31, 2022 10-K 2024-02-20
Q4 2021 $7.83M +$2.63M +50.7% Dec 31, 2021 10-K 2024-02-20
Q4 2020 $5.19M +$4.96M +2110% Dec 31, 2020 10-K 2023-02-23
Q4 2019 $235K +$235K Dec 31, 2019 10-K 2022-02-24
Q4 2018 $0 $0 Dec 31, 2018 10-K 2021-03-01
Q3 2018 $0 -$1.5M -100% Sep 30, 2018 10-Q 2018-11-01
Q1 2018 $0 -$1.5M -100% Mar 31, 2018 10-Q/A 2018-07-06
Q4 2017 $0 -$1.5M -100% Dec 31, 2017 10-K 2020-02-24
Q3 2017 $1.5M $0 0% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 $1.5M -$5.2M -77.6% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $1.5M -$4.8M -76.2% Mar 31, 2017 10-Q 2017-05-05
Q4 2016 $1.5M -$1.82M -54.9% Dec 31, 2016 10-K 2019-02-26
Q3 2016 $1.5M +$1.1M +275% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 $6.7M Jun 30, 2016 10-Q 2016-08-05
Q1 2016 $6.3M Mar 31, 2016 10-Q 2016-05-05
Q4 2015 $3.32M +$1.82M +122% Dec 31, 2015 10-K/A 2018-07-06
Q3 2015 $400K -$1.1M -73.3% Sep 30, 2015 10-Q 2015-11-06
Q4 2014 $1.5M +$1.5M Dec 31, 2014 10-K 2017-03-01
Q3 2014 $1.5M Sep 30, 2014 10-Q 2014-11-13
Q2 2014 $1.52M Jun 30, 2014 10-Q 2014-08-14
Q1 2014 $1.52M Mar 31, 2014 10-Q 2014-05-15
Q4 2013 $0 Dec 31, 2013 10-K 2016-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.